Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1996
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017863A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996WO1996017850A1 Cephem compounds and pharmaceutical use thereof
06/13/1996WO1996017849A1 7-alkylidene cephalosporanic acid derivatives and methods of using the same
06/13/1996WO1996017845A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996WO1996017830A1 Compounds for inhibition of gastric acid secretion
06/13/1996WO1996017615A1 Viscous liquid conditioning topical germicides
06/13/1996WO1996006620A3 Lipid analogs for treating viral infections
06/13/1996CA2206965A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996CA2205896A1 Compounds for inhibition of gastric acid secretion
06/13/1996CA2204738A1 Induction of cytotoxic t-lymphocyte responses
06/12/1996EP0716148A2 Recombinant alphavirus vectors
06/12/1996EP0716093A1 Erythromycin derivatives, their process of preparation and application as medicaments
06/12/1996EP0715856A1 Keratin-storable antifungal composition for external use
06/12/1996EP0715849A1 A method of inhibiting endotoxin induced effects
06/12/1996EP0715626A1 Antimicrobial quinolinyl-(1h-1,2,4-triazol-1-yl)alkanol derivatives
06/12/1996EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy
06/12/1996EP0590044A4 Composition and treatment with biologically active peptides having c-terminal substitutions
06/12/1996EP0538353B1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs
06/12/1996EP0498843B1 Oligonucleotide analogs with novel linkages
06/12/1996EP0497820B1 Ribozyme inhibitors
06/12/1996CN1124502A Mammal cell lines and method of obtaining glycoproteins
06/12/1996CN1124456A Gonococcal anti-idiotypic antibodies and methods and compositions using them
06/12/1996CN1124143A Powder preparation for healing damaged skin
06/11/1996US5525627 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity
06/11/1996US5525612 Antiviral pharmaceutical composition
06/11/1996US5525611 Antitumor agent, bactericides, viricides
06/11/1996US5525609 Alkaloids from Mappia foetida, the use thereof and formulations containing them
06/11/1996US5525598 Viricides or antitumor agents
06/11/1996US5525594 Administering a plant extract oenotheine b to inhibit 5 alpha-reductase
06/11/1996US5525590 Immunosuppressants, antiinflammatory and antiparasitic
06/11/1996US5525513 Isolated mammalian dna sequence which hybridizes to specified primers
06/11/1996US5525338 Detection and therapy of lesions with biotin/avidin conjugates
06/11/1996US5525325 Form metal complexes active as photosensitizers which are stable and water soluble
06/06/1996WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination
06/06/1996WO1996016967A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/06/1996WO1996016966A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
06/06/1996WO1996016675A2 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
06/06/1996WO1996016672A1 Serially passaged african green monkey kidney cells
06/06/1996WO1996016666A1 Method for the specific immunoadsorption of selected pathogenic factors
06/06/1996WO1996016664A1 Compositions for the treatment of parasitic and fungal infections
06/06/1996WO1996016652A2 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections
06/06/1996WO1996016650A1 Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof
06/06/1996WO1995032298A3 Safe vectors for gene therapy
06/06/1996CA2206511A1 Compositions for the treatment of parasitic and fungal infections
06/06/1996CA2206315A1 Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof
06/06/1996CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/05/1996EP0714513A1 Molecular clones producing recombinant dna antigens of the hards virus
06/05/1996EP0714446A1 Chitinase, dna coding therefor and plants containing same
06/05/1996EP0714439A1 Recombinant humanized anti-human immunodeficiency virus antibody
06/05/1996EP0714436A1 Oligonucleotides with activity against human immunodeficiency virus
06/05/1996EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
06/05/1996EP0714393A1 Thiazoles as antiviral
06/05/1996EP0714307A1 Vaccine compositions
06/05/1996EP0714306A1 Inactivated respiratory syncytial viral vaccines
06/05/1996EP0714297A1 Novel 1,2-dithiin antiinfective agents
06/05/1996EP0497825B1 Anti-viral material
06/05/1996CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation
06/05/1996CN1124026A Thioindole pyperidinyl derivatives used as antalgics
06/05/1996CN1124013A Influenza vaccine compositions containing 3-O-deacylated monophosphoryl lipid a
06/05/1996CN1124012A Arylating medicaments
06/05/1996CN1123665A Long-effect and broad-spectrum antibiotic granules and its production
06/04/1996US5523415 Bactericides
06/04/1996US5523406 2-substituted tertiary carbinol derivatives of 1,5-iminosugars
06/04/1996US5523403 Tropone-substituted phenyloxazolidinone antibacterial agents
06/04/1996US5523389 Inhibitors of human immunodeficiency virus
06/04/1996US5523288 Concurrently administering protein product and polymyxin b to treat infections caused by escherichia, providencia or pseudomonas species
06/04/1996US5523089 Borrelia antigen
05/1996
05/30/1996WO1996016184A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems
05/30/1996WO1996016178A1 Immunogens for stimulating mucosal immunity
05/30/1996WO1996016173A2 Modified proteinase inhibitors
05/30/1996WO1996016055A1 A new physically stable solid form of a fluoroquinolone
05/30/1996WO1996016053A1 Phthalide compounds and their production process
05/30/1996WO1996016046A2 Novel benzyl pyrimidines
05/30/1996WO1996016042A1 Antibacterial dibenzimidazole derivatives
05/30/1996WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates
05/30/1996WO1996015798A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
05/30/1996WO1996015792A1 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones
05/30/1996WO1996015778A1 Polynucleotide compositions
05/30/1996WO1996012807A3 Hepatitis e virus antigens and uses therefor
05/30/1996DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation
05/30/1996CA2205504A1 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
05/30/1996CA2205486A1 Polynucleotide compositions
05/30/1996CA2205356A1 Modified proteinase inhibitors
05/30/1996CA2205130A1 Immunogens for stimulating mucosal immunity
05/30/1996CA2204639A1 Antibacterial dibenzimidazole derivatives
05/30/1996CA2204252A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems
05/30/1996CA2201735A1 A new physically stable solid form of a fluoroquinolone
05/29/1996EP0713915A1 Hog cholera virus vaccine and diagnostic
05/29/1996EP0713700A1 mUse of lauric acid or a monogryceride of a C8-C16 fatty acid for inhibiting Helicobacter
05/29/1996EP0713530A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins
05/29/1996EP0713527A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms
05/29/1996EP0713487A1 Novel quinolone carboxylic acid derivatives
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0713397A1 Vaccine containing live virus for therapy of viral diseases and malignancies
05/29/1996EP0713396A1 Medical use of stem bromelain protease
05/29/1996EP0641346B1 7'-amino-naphthazarin antibiotic derivatives
05/29/1996EP0233255B1 Conversion of cephalosporin hydrohalide salt to alkali metal salt
05/29/1996CN1123549A Crystalline benzathine salt of cefonicid and its preparation
05/29/1996CN1123544A Optically active 3-(1-(alkylamino)) alkyl pyrrolidines
1 ... 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 ... 1798